The Valley Desk

NCT01110902 · Interventional trial

Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)

Overall registry status Completed

Phase 3

Conditions Major Depressive Disorder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov